Millions of Medicare beneficiaries have started comparing prescription prices on TrumpRx.gov, the no-cost federal price-comparison website the Trump administration launched in February 2026, and many assume the savings will work the same way insurance does. They do not. The Centers for Medicare & Medicaid Services states plainly on Medicare.gov that using TrumpRx.gov’s cash-price coupons instead of a Part D plan is not creditable coverage, so none of that spending applies toward a beneficiary’s annual drug deductible or out-of-pocket maximum. The distinction matters most for anyone splitting prescriptions between the two systems without realizing only one side of the ledger is being tracked.
How TrumpRx.gov’s Cash Discounts Actually Work
President Donald J. Trump announced the site’s launch on February 5, 2026, following an executive order the previous year directing federal officials to bring American drug prices in line with the lowest prices paid by other wealthy nations, an approach the administration calls most-favored-nation pricing. The first five manufacturers to sign pricing deals, AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer, supplied roughly 40 branded drugs at launch, with additional companies and products added in the months since. The site sits alongside, rather than inside, the existing Medicare drug benefit structure.
TrumpRx.gov does not sell medications directly to patients. Depending on which manufacturer supplies a given drug, a patient with a valid prescription accesses savings through a printable or downloadable coupon, or through a purchasing channel the manufacturer has integrated directly into the site, according to the White House’s official fact sheet on the launch. Medicare.gov separately instructs beneficiaries to visit TrumpRx.gov to compare its prices against what they already pay under an existing Part D plan, treating the site as a shopping tool layered on top of coverage rather than a substitute for it.
Inside the kit: 51 state Medicare cost-help packs, the new Part D out-of-pocket cap, the prior-authorization appeal steps and a medication and cost tracker. Open The Medicare Cost & Coverage Protection Kit.
Why the Coupons Don’t Count as Creditable Coverage
Creditable coverage is a specific legal term Medicare built into the Part D program: CMS defines it as coverage expected to pay, on average, at least as much as the standard Medicare prescription drug benefit. Medicare.gov states directly that TrumpRx and other discount cards are not considered creditable coverage, and that using them instead of a Part D plan to buy a drug means the purchase does not count toward the deductible or the out-of-pocket maximum Medicare tracks each year. A prescription filled through TrumpRx’s cash price is a genuine discount at the register, but it never becomes a data point inside a beneficiary’s Part D claims history.
The distinction carries a second consequence beyond the deductible math. CMS’s creditable-coverage rules impose a late-enrollment penalty on anyone who goes 63 days or longer without creditable drug coverage after becoming eligible for Part D, and that penalty calculation has no mechanism for crediting time spent buying drugs through a cash-discount site instead of enrolling in a plan. Someone who delays Part D enrollment because TrumpRx.gov coupons are covering current prescriptions is not building any protection against that penalty, no matter how much the coupons save at the pharmacy counter.
The mechanics explain why CMS frames TrumpRx as a comparison tool rather than a coverage option. A beneficiary can use it to find a lower cash price on a specific refill, then still rely on the Part D plan for the deductible and catastrophic protection the cash price cannot provide. Treating the two as interchangeable is where the ledger splits: one column reflects what was actually paid at the pharmacy counter, and the other reflects what Medicare will recognize when it calculates how close a beneficiary is to catastrophic coverage.
The $2,400 Threshold Extra Help Reaches That TrumpRx Cannot
Medicare’s Extra Help program shows what a purchase that does count looks like. Beneficiaries who qualify for Extra Help pay a $0 Part D plan premium and a $0 deductible in 2027, along with copays capped at $5.80 for a generic drug and $14.40 for a brand-name drug, and once total drug costs, including amounts paid on their behalf, reach $2,400, they owe nothing further for covered drugs for the rest of the year. Every one of those dollars, whether paid by the beneficiary or covered by the program, is tracked toward that $2,400 line because Extra Help is creditable Part D coverage.
Income and resource limits determine who receives that tracking automatically. CMS lists the 2026 limits for Extra Help at $23,940 in income and $18,090 in resources for an individual, and $32,460 in income and $36,100 in resources for a married couple, with anyone who receives full Medicaid, a Medicare Savings Program, or Supplemental Security Income qualifying without a separate application. Beneficiaries above those limits, and therefore ineligible for Extra Help, are precisely the group most likely to turn to TrumpRx.gov for relief, and precisely the group whose cash-price purchases will never reach a Medicare-tracked threshold at all.
Medicare offers a separate option for beneficiaries who want predictable bills without changing what counts toward coverage. The Medicare Prescription Payment Plan lets anyone with a Part D plan or a Medicare Advantage plan with drug coverage spread their own out-of-pocket drug costs across the calendar year instead of paying the pharmacy directly each month, at no cost to participate. CMS is explicit that the payment plan does not lower drug costs or save money on its own; it only changes the timing of payments that still flow through, and count toward, a beneficiary’s existing Part D coverage.
The two federal tools sit on opposite sides of the same accounting line. The Prescription Payment Plan reorganizes bills that already count toward a Part D deductible and out-of-pocket maximum, while TrumpRx.gov’s coupons produce savings that never enter that calculation, no matter how large the price cut looks at the pharmacy counter. CMS has not announced any plan to change that treatment, and Medicare.gov’s own guidance leaves the distinction unambiguous: a discount card is not creditable coverage, and money saved through one does not move a beneficiary any closer to meeting a Part D deductible or reaching the out-of-pocket maximum for the year.
Price Lookups and What Counts Toward a Deductible
The rule above establishes what does not count toward a Part D deductible, but it does not identify which prescriptions on a specific plan’s formulary would count, or how close a full year of copays sits to that plan’s out-of-pocket cap. Medicare.gov does not print a personal worksheet next to that warning, and no federal form exists to reconcile a TrumpRx receipt against a plan’s running deductible total. That gap between the federal rule and a beneficiary’s own paperwork is where a state-specific reference becomes useful.
The Medicare Cost & Coverage Protection Kit is a 10-page kit built around 51 state Medicare cost-help packs and a plain explanation of the new Part D out-of-pocket cap.
Look up the new Part D out-of-pocket cap in The Medicare Cost & Coverage Protection Kit.
This article was researched and drafted with the assistance of AI and reviewed by The Money Overview editorial team.
